HUP0102436A2 - Reboxetin alkalmazása gyógyszer előállítására idegi rendellenességek ellen - Google Patents

Reboxetin alkalmazása gyógyszer előállítására idegi rendellenességek ellen

Info

Publication number
HUP0102436A2
HUP0102436A2 HU0102436A HUP0102436A HUP0102436A2 HU P0102436 A2 HUP0102436 A2 HU P0102436A2 HU 0102436 A HU0102436 A HU 0102436A HU P0102436 A HUP0102436 A HU P0102436A HU P0102436 A2 HUP0102436 A2 HU P0102436A2
Authority
HU
Hungary
Prior art keywords
disorders
reboxetin
medicament
preparation
addiction
Prior art date
Application number
HU0102436A
Other languages
English (en)
Inventor
Fred Hassan
John Michael Mccall
Duncan Paul Taylor
Erik Ho Fong Wong
Philip F. Von Voigtlander
Original Assignee
Pharmacia And Upjohn Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia And Upjohn Co. filed Critical Pharmacia And Upjohn Co.
Publication of HUP0102436A2 publication Critical patent/HUP0102436A2/hu
Publication of HUP0102436A3 publication Critical patent/HUP0102436A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)

Abstract

A találmány tárgya reboxetin és származékai és/vagy gyógyászatilagelfogadható sói alkalmazása olyan gyógyszer előállítására, amellyelfüggőségi rendellenességek, pszichoaktív anyag használatirendellenességek, intoxikációs rendellenességek, inhalálásirendellenességek, alkoholfüggőség, dohány- vagy nikotinfüggőség éskoncentrálási hiány hiperaktivitás rendellenesség (ADHD) kezelhető. Ó
HU0102436A 1998-04-09 1999-04-02 Use of reboxetin for preparation of medicament for nervous disorders HUP0102436A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8123198P 1998-04-09 1998-04-09
PCT/US1999/004289 WO1999052531A1 (en) 1998-04-09 1999-04-02 New treatments for nervous disorders

Publications (2)

Publication Number Publication Date
HUP0102436A2 true HUP0102436A2 (hu) 2001-11-28
HUP0102436A3 HUP0102436A3 (en) 2002-01-28

Family

ID=22162900

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102436A HUP0102436A3 (en) 1998-04-09 1999-04-02 Use of reboxetin for preparation of medicament for nervous disorders

Country Status (24)

Country Link
US (1) US6352986B1 (hu)
EP (1) EP1069900B1 (hu)
JP (1) JP2002511414A (hu)
KR (1) KR20010034758A (hu)
CN (1) CN1301164A (hu)
AT (1) ATE301462T1 (hu)
AU (1) AU756373B2 (hu)
BR (1) BR9909478A (hu)
CA (2) CA2634698A1 (hu)
CZ (1) CZ297346B6 (hu)
DE (1) DE69926616T2 (hu)
DK (1) DK1069900T3 (hu)
EA (1) EA200001049A1 (hu)
ES (1) ES2244189T3 (hu)
HU (1) HUP0102436A3 (hu)
IL (1) IL138855A0 (hu)
NO (1) NO20005059L (hu)
NZ (1) NZ507398A (hu)
PL (1) PL193797B1 (hu)
PT (1) PT1069900E (hu)
SK (1) SK14492000A3 (hu)
TR (1) TR200002868T2 (hu)
WO (1) WO1999052531A1 (hu)
ZA (1) ZA200004454B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586427B2 (en) * 1998-04-09 2003-07-01 Pharmacia & Upjohn Company Treatments for nervous disorders
ES2246485T3 (es) * 1999-07-01 2006-02-16 PHARMACIA & UPJOHN COMPANY LLC (s,s)-reboxetina para tratar la incontinencia.
EP1459751B1 (en) * 1999-07-01 2005-09-14 Pharmacia & Upjohn Company LLC (S,S)-reboxetine for treating migraine headaches
EP1267859A2 (en) * 2000-03-07 2003-01-02 Eli Lilly And Company Use of norepinephrine reuptake inhibitors for the treatment of psoriasis
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
US20040102440A1 (en) * 2002-07-01 2004-05-27 Wong Erik Ho Fong Method of promoting smoking cessation
ES2708552T3 (es) 2002-12-20 2019-04-10 Niconovum Ab Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC)
JP5258561B2 (ja) 2005-07-15 2013-08-07 アルバニー モレキュラー リサーチ， インコーポレイテッド アリール置換およびヘテロアリール置換テトラヒドロベンズアゼピンならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するためのその使用
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
ES2528404T3 (es) 2009-05-12 2015-02-10 Bristol-Myers Squibb Company Formas cristalinas de (S)-7-([1,2,4]triazol[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y sus usos
ES2662072T3 (es) 2009-05-12 2018-04-05 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y uso de la misma
WO2012024397A2 (en) 2010-08-17 2012-02-23 Albany Molecular Research, Inc. 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
EP0072177B1 (en) * 1981-08-07 1987-01-07 Holset Engineering Company Limited Impeller for centrifugal compressor
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
US5281624A (en) * 1991-09-27 1994-01-25 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
ZA958725B (en) * 1994-10-20 1997-04-16 Lilly Co Eli Treatment of disorders with duloxetine
US5658590A (en) * 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
CA2227410A1 (en) * 1995-07-24 1997-02-06 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
UA56257C2 (uk) 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
CA2304112A1 (en) * 1997-09-23 1999-04-01 John Harrison Heiligenstein Treatment of attention-deficit/hyperactivity disorder

Also Published As

Publication number Publication date
DE69926616T2 (de) 2006-05-24
AU756373B2 (en) 2003-01-09
CZ297346B6 (cs) 2006-11-15
HUP0102436A3 (en) 2002-01-28
PL346293A1 (en) 2002-01-28
PT1069900E (pt) 2005-10-31
ZA200004454B (en) 2002-04-24
EA200001049A1 (ru) 2001-04-23
KR20010034758A (ko) 2001-04-25
NO20005059D0 (no) 2000-10-06
SK14492000A3 (sk) 2001-06-11
EP1069900A1 (en) 2001-01-24
CA2321157A1 (en) 1999-10-21
IL138855A0 (en) 2001-10-31
DE69926616D1 (de) 2005-09-15
US6352986B1 (en) 2002-03-05
JP2002511414A (ja) 2002-04-16
ES2244189T3 (es) 2005-12-01
WO1999052531A1 (en) 1999-10-21
ATE301462T1 (de) 2005-08-15
EP1069900B1 (en) 2005-08-10
CZ20003671A3 (en) 2001-06-13
CN1301164A (zh) 2001-06-27
PL193797B1 (pl) 2007-03-30
BR9909478A (pt) 2000-12-19
AU3449499A (en) 1999-11-01
NZ507398A (en) 2004-01-30
DK1069900T3 (da) 2005-10-31
NO20005059L (no) 2000-10-06
TR200002868T2 (tr) 2001-01-22
CA2634698A1 (en) 1999-10-21

Similar Documents

Publication Publication Date Title
HUP0102436A2 (hu) Reboxetin alkalmazása gyógyszer előállítására idegi rendellenességek ellen
HUP0300030A2 (en) Bupropion metabolites and methods of their synthesis and use and pharmaceutical compositions containing them and and their use
Malhotra et al. Nicotine and periodontal tissues
HUP0301868A2 (hu) Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz
UA102517C2 (ru) Замещенные производные морфолина и тиоморфолина, фармацевтическая композиция на их основе и их применение для производства лекарственного средства для лечения расстройства или заболевания центральной нервной системы
MY127739A (en) Use of pramipexole for the treatment of addictive disorders
HUP0100900A2 (hu) Gyógyászatilag aktív morfolinolszármazékok, és az ezeket tartalmazó gyógyszerkészítmények
DE60140466D1 (de) Methode zur reduktion des schmerzempfindens
HUP0400782A2 (hu) Antikolinergikumokon és PDE-IV inhibitorokon alapuló új gyógyszerkészítmények
ATE302774T1 (de) Arzneimittel enthaltend betamimetika und ein neues anticholinergikum
HUP0301458A2 (hu) Benzoxazinonszármazékok, eljárás előállításukra és a vegyületek felhasználása
HUP0300048A2 (hu) Transzdermális vagy transzmukozális dohányzásról leszoktató készítmények, melyek nikotintartalmú hatóanyagkombinációt tartalmaznak és alkalmazásuk
ATE249828T1 (de) Verwendung von isatin- und oxindolderivaten zur herstellung von arzeneimittel für die behandlung von mykobakteriellen erkrankungen
ATE447403T1 (de) Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
EE200300513A (et) Piperasinoderivaadid, nende kasutamine hingamisteede haigusnähte leevendavate ravimite valmistamiseks ning neid sisaldavad ravimid
KR20100069333A (ko) 흡입식 경구 투여 금연 보조제
SE0102887D0 (sv) New formulation
MX2023005462A (es) Compuestos macrociclicos y metodos para usarlos.
HUP0301408A2 (hu) Szulodexid alkalmazása diabetikus vesebetegség kezelésére szolgáló orális gyógyszerkészítmény előállítására
HUP0101748A2 (hu) Reboxetin alkalmazása idegrendszeri zavarok kezelésére szolgáló gyógyszerkészítmények előállítására
HUP0102116A2 (hu) Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása
DE69910242D1 (de) Verwendung eines Nikotin-Rezeptor Agonisten zur Herstellung eines Medikaments zur Behandlung von Zwangsneurosen
SE0102888D0 (sv) New formulation
HUP0401587A2 (hu) Új elnyújtott kibocsátású orális adagolási forma

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees